TWiV 1046: Clinical update with Dr. Daniel Griffin

In his weekly clinical update, Dr. Griffin discusses wastewater surveillance data as a complement to emergency department visit data for tracking the incidence of influenza A and RSV, chatbot-delivered online intervention to promote seasonal Influenza vaccination during the COVID-19 pandemic, temporal assessment of disparities in California COVID-19 mortality by industry, modeling the impact of a high-uptake bivalent booster scenario on the COVID-19 burden and healthcare costs in New York City, can high COVID-19 vaccination rates in adults help protect unvaccinated children, Nirmatrelvir/Ritonavir use and hospitalizations or death in previously uninfected non-hospitalized high-risk population with COVID-19, Optimal duration of systemic corticosteroids in COVID-19 treatment, and vaccination after developing long COVID.

Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

Become a patron of TWiV!

• Wastewater surveillance data as a complement to tracking incidence of influenza A and RSV (CDC)
• Chatbot-delivered online intervention to promote seasonal influenza vaccination (JAMA)
• Temporal assessment of disparities in California COVID-19 mortality by industry (AOE)
• CDC/HICPAC’s plan to weaken guidance for health care respiratory protection and infection control (NNU)
• Modelling the impact of a high-uptake bivalent booster scenario on COVID-19 burden (The Lancet)
• Can high COVID-19 vaccination rates in adults help protect unvaccinated children? (ES)
• Paxlovid use and hospitalizations or death in previously uninfected high-risk population with COVID-19 (JID)
• Optimal duration of systemic corticosteroids in COVID-19 treatment (OFID)
• Vaccination after developing long COVID (IJID)
• Contribute to our Floating Doctors fundraiser at PWB
• Letters read on TWiV 1046
• Dr. Griffin’s COVID treatment summary (pdf)
• Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to [email protected]